Abstract
Unlike mammals, broiler chickens require larger quantities of sulphur amino acids (SAA) to maximize their performance. Besides their various functions in metabolism, the high requirements for both methionine and cysteine are attributed to feather formation during growth. The concentration of total sulphur amino acids in feather protein is about 2.5 times higher than that of feather-free carcass (Stilborn et al., 1997 (Stilborn et al., , 2010 . Furthermore, the average cysteine to methionine ratio in feather protein was found to be 7-13:1 (Stilborn et al., 1997) and cysteine was thus considered to be the fi rstlimiting amino acid in most poultry diets (Baker, 1976) . For practical reasons, however, the diets are commonly supplemented with DL-methionine (DLM) or its hydroxy analogue, i.e. DL-2-hydroxy-4(methylthio)butanoic acid (methionine hydroxy analogue free acid, MHA-FA).
Even though a large number of studies comparing the bioavailability of DLM and MHA-FA in broilers have been carried out during the last 40 years, there is still a considerable controversy regarding this question. Several authors (Waldroup et al., 1981; Liu et al., 2006; Vázquez-Añón et al., 2006) found that both sources of methionine activity were equivalent on equimolar basis in promoting chicken growth. In contrast, the results of other studies (Huyghebaert, 1993; Lemme et al., 2002; Payne et al., 2006; Dilger and Baker, 2008) indicated that MHA-FA was substantially less biologically effi cient than DLM. There are many factors which may be responsible for the inconsistent results described in the literature, including the composition of basal diets, range of methionine source supplements, SAA levels relative to the requirement or methionine to cysteine ratio as well as their levels relative to other essential AA. The selection of a proper method of experimental data interpretation may also play a signifi cant role.
The aim of the present experiment was to determine the biological eff ectiveness of MHA-FA relative to DLM added to practical-type broiler diets in graded amounts, using growth performance and carcass quality as the criteria of response.
MATERIAL AND METHODS
The experiment was conducted at the International Poultry Testing Station Ústrašice. The animal procedures were reviewed and approved by the Animal Care Committee of the Mendel University in Brno. A total of 7560 day-old male Ross 308 broiler chicks were randomly assigned to 9 treatments in such a way as to ensure similar mean body weights across treatments. There were six replicates per treatment (140 chicks per pen). Chickens were kept in the windowless house with full climatic control, on deep litter from wood shavings. Each pen was equipped with manually fi lled tube feeders and nipple drinkers. The stocking density was 17 broilers per square meter. Heating and lighting programmes were in accordance with Ross Broiler Management Manual (2009 MHA-FA containing 88 % active substance and 12 % water were added to the diets in form of a dry premix using silica powder as a premix carrier. During the experiment, the chickens were allowed free access to pelleted diets and water. The diets were analyzed for nitrogen using Dumas procedure and for protein-bound and free amino acids by ion-exchange chromatography as described by Llames and Fontaine (1994) (Tab. I). Supplemented liquid MHA-FA was analyzed using the method of Naumann et al. (1997) .
The performance data were analyzed as completely randomized block design using analysis of variance procedures. When signifi cant value for treatment eff ect (P < 0.05) was observed, the diff erences between means were assessed using Tukey HSD test. Floor pen was the experimental unit for all analyses. To estimate the biological availability of MHA-FA relative to DLM, a multiexponential model proposed by Noll et al. (1984) and Littell et al. (1997) was used: The relative bioavailability value (RBV) for liquid MHA-FA was defi ned as the ratio of steepness coeffi cients c 2 /c 1 . To calculate the confi dence intervals for the c 2 /c 1 ratio, the model was reparametrized yielding the following equation:
).
All statistical calculations were performed using Statgraphic Plus package (version 3.1, Statistical graphic Corp., Rockville, MD, USA). The parameters of the exponential model were estimated using Marquardt iterative search method.
RESULTS AND DISCUSSION
Mean body weights of chickens during the experiment are summarized in Tab. III. In general, the weight of broilers gradually increased with increasing levels of both methionine sources, thus demonstrating a clear SAA defi ciency of the basal diets. The growth rate of chickens receiving diets supplemented with 0.16 or 0.28 % DLM was equal to or better than the values given in the Ross 308 performance objectives (Ross 308 Broiler Performance Objectives, 2012) . The response to corresponding MHA-FA supplements was numerically lower in most cases, but the diff erences as assessed by the Tukey HSD test were not signifi cant suggesting no diff erences between effi ciency of products. However, this comparison can result in misleading conclusion. As Hoehler (2006) pointed out, the comparison of pairs of treatments from a dose-response design cannot explain how much of a nutrient source is needed to replace another one without aff ecting performance. In addition, ANOVA and multiple range tests are o en not sensitive enough to detect small diff erences such as between treatments DLM3 and DLM4. The small diff erence between DLM3 and DLM4 levels indicated a diminishing returns pattern of the dose-response relationship and suggested that SAA intake was close to the requirement in these groups. Similar results were obtained with feed conversion ratio (Tab. IV). The data for the whole experiment showed better feed conversion in chickens fed DLM-supplemented diets, but the improvement over the MHA-FA counterparts was insignifi cant. Moreover, at the highest inclusion level, the performance of broilers were similar using either products.
The changes in carcass and breast meat yields in response to methionine source supplements are shown in Tab. V. Similar response have been observed in other studies (Schutte and Pack, 1995; Wallis, 1999; Lemme et al., 2002; Ahmed and Abbas, 2011) . The increase in breast meat yield is assumed to be due at least partly to decreased fat deposition observed in most experiments with methionine supplements (Schutte and Pack, 1995; Wallis, 1999; Ahmed and Abbas, 2011) . It seems that these changes might be due to the redistribution of dietary energy towards higher protein deposition resulting from better amino acid balance or the stimulating eff ect of methionine on the oxidative catabolism of fatty acids via its participation in carnitine synthesis (Schutte et al., 1997) . Methionine-induced alterations of metabolic pathways controlling lipogenesis may also be involved (Takahashi and Akiba, 1995) . Zhai et al. (2012) muscle protein deposition might have been due to sarcoplasmic rather than myofi brillar hypertrophy. Because of the diminishing returns pattern observed in all the response criteria studied, exponential model by Littell et al. (1997) was used to estimate the bioavailability of MHA-FA relative to DLM. The comparison was made on product basis. The parameters of the model with their standard errors and confi dence intervals for various response criteria are summarized in Tab. VI. As evidenced by the R-squared statistic, the model fi tted the experimental data well for both methionine sources, explaining 73-82 % of total variability in the response. As shown in Figs. 1 and 2 , the response of chickens to DLM supplements was superior to that achieved with MHA-FA, particularly at low levels of supplementation. It is well known that the response to a limiting amino acid (and therefore the sensitivity of an assay) diminishes as its supply approaches optimum requirement (Fisher et al., 1973; Fuller and Garthwaite, 1993) . Fitting experimental data to the exponential model enables to estimate real availability values, representing the whole range of DLM and MHA-FA intake. The RBV of MHA-FA in terms of body weight estimated by this way was 0.68, i.e. 68 % as compared with DLM (100 %) (Fig. 1 A) . The same value was calculated when body weight gain was used as a criterion of response (data not given). The upper 95 % confi dence interval of the c 2 /c 1 ratio was higher than 0.88 (Tab. VII), thus indicating an insignifi cant diff erence between DLM and MHA-FA
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Time interval (days) Sauer et al. (2008) showed that the RBV of MHA-FA was 81 % on equimolar basis, i.e. 71 % on product basis. The RBV for feed conversion found in the present study (70 %, Fig. 1 B) was slightly higher than that for body weight. In contrast, the mean values calculated by both Lemme et al. (2002) and Sauer et al. (2008) were lower (66 and 64 %, respectively). However, the literature data were rather variable in this respect, ranging from 51 % (Lemme et al., 2002; Payne et al., 2006) up to 73 % (Esteve-Garcia and Llaurado, 1997) and 76 % (Jansman et al., 2003) . The RBV was not signifi cantly diff erent from 0.88 in the present study (Tab. VII). When carcass yield was used as an independent variable in the exponential model, the resulting RBV was estimated to be 0.52 (Fig. 2 A) . The 95 % confi dence interval for c 2 /c 1 ratio (27.5-76.8, Tab. VII) demonstrated that the biological availability of the active substance of MHA-FA (88 % by weight) was signifi cantly lower than that of DLM. Breast meat yield response to DLM or MHA-FA additions followed a similar pattern (Fig. 2 B) . The estimated MHA-FA availability was 56.8 % (35.8-77.9) and was signifi cantly less than 88 %. Despite the diff erences in body weight and methods of carcass evaluation, the present data on breast meat yield agree relatively well with the results of other studies. On product basis, the RBVs of MHA-FA were reported to be 45 % (Esteve-Garcia and Llaurado, 1997), 48-54 % (Payne et al., 2006) , 53-64 % (Lemme et al., 2002) and 63 % (Wallis, 1999) . In most cases, the bioavailability of MHA-FA was signifi cantly lower than that of DLM.
Considering the concentration of active substance in DLM (99 %) and liquid MHA-FA (88 %) and the molecular weight (DLM 149.21 g/mol; MHA-FA 150.20 g/mol), the relative bioavailability values as well as their confi dence intervals estimated on product basis can be recalculated to equimolar basis multiplying the respective values by (0.99 * 150.20)/ (0.88 * 149.21). The data given in Tab. VII show that, in comparison with equimolar levels of DLM, the MHA-FA availability was lower in all cases, the greatest diff erence being found in carcass and breast meat yields. The sensitivity of both absolute and relative breast meat yield to dietary methionine levels has been demonstrated in many studies (Schutte and Pack, 1995; Zhai et al., 2012) . Also, it has been shown that the optimal levels of SAA (as well as lysine) for breast meat deposition are higher than for body weight gain (Bartov and Plavnik, 1998) . The clear-cut response of breast meat yield to DLM supplements is of particular importance, since the proportion of breast meat in portioned birds may have a great impact on overall profi tability in poultry industry (Pack et al., 2003 Various hypotheses have been proposed to explain lower bioavailability of MHA-FA relative to DLM. The commercial MHA-FA product contains about 65 % monomers and 23 % of dimers and oligomers. It has been suggested that nonmonomeric forms of MHA-FA have a lower bioavailability than monomers (Van Weerden et al., 1992) . In contrast, Martín-Venegas et al. (2006) found that the presence of oligomers is not the limiting factor in MHA-FA utilization. The diff erence in the bioavailability of both methionine sources may also be explained by a decreased intestinal absorption of MHA-FA relative to DLM as suggested by Lingens and Molnar (1996) and Maenz and Engele-Schaan (1996) . This might be due to the diff erent absorption mechanisms of both methionine sources (Maenz and Engele-Schaan, 1996) or the interaction of MHA-FA with gut microfl ora (Drew et al. 2003) . The latter authors, using 3 H-labelled L-forms of methionine and MHA-FA, demonstrated that intestinal bacteria signifi cantly reduced the apparent absorption of MHA-FA from the intestinal tract of broiler chickens. Another potential hypothesis on the inferior bioavailability of MHA-FA was proposed by Dilger and Baker (2008) and Baker (2009) , who found that, at severe defi ciency of methionine, the utilization of both MHA-FA and its calcium salt was lower in the presence than absence of excess cysteine. The authors concluded that cysteine to methionine ratio might be an important factor aff ecting the bioavailability of MHA-FA relative do DLM.
The exponential model used in the present study was based on an assumption of a common asymptote for both methionine sources. This assumption has been questioned by Kratzer and Littell (2006) who suggested to use two separate models (with diff erent asymptotes) when comparing DLM and MHA availability. In contrast, Piepho (2006) considered the conclusions by Kratzer and Littell (2006) not fully justifi ed from a statistical point of view. To confront these two approaches, separate exponential models were fi tted to carcass and breast meat yield data (recalculated to equimolar basis) obtained in the present study as suggested by Kratzer and Littell (2006) . The resulting RBV for carcass yield was almost identical with that obtained with the common asymptote model (59.7 vs. 59.3 %) while the RBV for breast meat yield was about 8 % higher (69.6 vs. 64.6 %). In both cases, however, the values were considerably lower than 100 %, thus indicating lower bioavailability of MHA-FA. 
